Delivery Order SPE2DB22D3301-SPE2DB23FX9RB
- Not listed
- This federal contract award, valued at $6,771.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,497.44 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award is a delivery order valued at $10,205.77 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, with a period of performance through March 31, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, valued at $77,261.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award to AmerisourceBergen Drug Corp is a Delivery Order valued at $15,894.58, issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) to provide RINVOQ ER 30 MG TABLET medication. The IDC is a $999,999,999 multiple-award contract with DLA Troop Support Medical that runs through November 2026, enabling efficient procurement of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract is a Delivery Order (SPE2DX15D3020|SPE2DX25FPYQB) with a Firm Fixed Price structure, valued at $36,622.16, and has an ultimate completion date of December 10, 2024. The contract provides for the delivery of RINVOQ ER 30 MG TABLET medical supplies. This award is part of a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,063.11 delivery order contract is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a prescription medication. The contract is a firm fixed price arrangement with a completion date of June 5, 2025. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,552.41 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $16,303.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $88,394.30. The contract is for the supply of RINVOQ ER 45 MG TABLET, a prescription medication, to the Defense Logistics Agency (DLA), a defense agency. The award has an ultimate completion date of August 2, 2024 and was made on August 1, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB23FX9RBDelivery Order
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $86,220.14 under the Defense Logistics Agency's (DLA) Indefinite Delivery Contract (IDC) for medical supplies and pharmaceuticals. The contract covers the delivery of 4559601204 - RINVOQ ER 15 MG TABLET UU 30S, a medication used to treat certain autoimmune disorders. This IDC, worth up to $999,999,999 and running through November 2026, serves as a key contracting vehicle for the DLA to procure a wide range of essential medical products, including specialty medications, generic drugs, vaccines, and medical devices, in support of military healthcare programs. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $86.2k | 1/13/23 |